Jefferies Starts Kymera Therapeutics (KYMR) at Buy
Tweet
Share
E-mailGet Alerts KYMR Hot Sheet
Price: $117.39 +2.60%
Rating Summary:
26 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
26 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Jefferies analyst Kelly Shi initiates coverage on Kymera Therapeutics (NASDAQ: KYMR) with a Buy rating and a price target of $40.00.
For an analyst ratings summary and ratings history on Kymera Therapeutics click here. For more ratings news on Kymera Therapeutics click here.
Shares of Kymera Therapeutics closed at $33.77 yesterday.
You May Also Be Interested In
- ICICI Securities Resumes Oberoi Realty Ltd (OBER:IN) at Buy (1)
- Seaport Global Securities Starts ADI Global Distribution (ADIG) at Buy
- BofA Securities Resumes American Eagle Outfitters (AEO) at Underperform
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
